Utilization of gynecologic services in women with breast cancer receiving hormonal therapy (Q38877657)

5 July 2018

title

Utilization of gynecologic services in women with breast cancer receiving hormonal therapy (English)

1 reference

5 July 2018

10

Dawn L Hershman

1 reference

5 July 2018

Cande Ananth

8

Cande V Ananth

1 reference

5 July 2018

Jason D Wright

1

Jason D Wright

1 reference

5 July 2018

Ana I. Tergas

5

Ana I Tergas

1 reference

5 July 2018

Alfred I. Neugut

9

Alfred I Neugut

1 reference

5 July 2018

author name string

Vrunda B Desai

2

1 reference

5 July 2018

Ling Chen

3

1 reference

5 July 2018

William M Burke

4

1 reference

5 July 2018

June Y Hou

6

1 reference

5 July 2018

Melissa Accordino

7

1 reference

5 July 2018

language of work or name

English

0 references

publication date

21 March 2017

1 reference

5 July 2018

American Journal of Obstetrics and Gynecology

published in

1 reference

5 July 2018

volume

217

1 reference

5 July 2018

issue

1

1 reference

5 July 2018

page(s)

59.e1-59.e12

1 reference

5 July 2018

Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR).

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Meta-analysis of vascular and neoplastic events associated with tamoxifen

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Tamoxifen and endometrial cancer

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen

22 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Association of tamoxifen and uterine sarcoma

22 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring

22 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Uterine Side Effects of Tamoxifen: A Need for Systematic Pretreatment Screening

22 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.

22 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5499703

Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas

22 August 2018

1 reference

12 December 2020

Identification of women at high risk of developing endometrial cancer on tamoxifen

1 reference

12 December 2020

Committee Opinion No. 601

1 reference

12 December 2020

Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening

1 reference

12 December 2020

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1 reference

12 December 2020

Committee Opinion No. 663: Aromatase Inhibitors in Gynecologic Practice

1 reference

12 December 2020

Tamoxifen and the endometrium: findings of pelvic ultrasound examination

1 reference

12 December 2020

10.1016/J.AJOG.2017.03.011

Identifiers

DOI

1 reference

5 July 2018

PMC publication ID

5499703

1 reference

5 July 2018

PubMed publication ID

28341383

1 reference

5 July 2018